Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. The Dow Jones Industrial Average ( ^DJI) is trading up six points at 13,988 as of Thursday, Feb 14, 2013, 10:35 a.m. ET. During this time, 211.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 619.1 million. The NYSE advances/declines ratio sits at 1,183 issues advancing vs. 1,597 declining with 130 unchanged.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be Coca-Cola (NYSE: KO), which is sporting a two-cent gain to $37.23. This single gain is lifting the Dow Jones Industrial Average by 0.15 points or roughly accounting for 2.5% of the Dow's overall gain. Volume for Coca-Cola currently sits at 7.7 million shares traded vs. an average daily trading volume of 13.9 million shares. Coca-Cola has a market cap of $168.46 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 3.6% year to date as of Wednesday's close. The stock's dividend yield sits at 2.7%. The Coca-Cola Company, a beverage company, engages in the manufacture, marketing, and sale of nonalcoholic beverages worldwide. The company primarily offers sparkling beverages and still beverages. The company has a P/E ratio of 18.7, above the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Coca-Cola as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.